Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

Author: HarriganE P, LesemM D, ReevesK R, SwiftR H, ZajeckaJ M

Paper Details 
Original Abstract of the Article :
There is a clear need for effective, well-tolerated intramuscular (i.m.) agents for the acute control of agitated psychotic patients. Currently used agents, including conventional antipsychotics and/or benzodiazepines, may be associated with distressing side effects such as extrapyramidal side effec...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.4088/jcp.v62n0104

データ提供:米国国立医学図書館(NLM)

Intramuscular Ziprasidone: A Potential Solution for Managing Agitated Psychotic Patients

This study explores the therapeutic potential of [pharmacology] in managing [psychiatric disorders]. The researchers investigated the effectiveness of intramuscular (i.m.) ziprasidone, a medication commonly used to treat psychosis and agitation, in acutely controlling agitated psychotic patients. Their study compared two doses of ziprasidone (2 mg and 10 mg) and assessed their efficacy and tolerability. The study's findings suggest that i.m. ziprasidone can be an effective treatment option for managing agitation in psychotic patients, offering a potentially safer alternative to traditional antipsychotics.

Effective and Well-Tolerated Management of Agitation

The study demonstrated the efficacy of i.m. ziprasidone in managing agitated psychotic patients. The research found that both doses of ziprasidone (2 mg and 10 mg) were effective in reducing agitation, with a lower dose showing a favorable side effect profile. This finding suggests that i.m. ziprasidone could be a valuable addition to the treatment options for managing acute agitation in this patient population.

Improving Patient Care and Well-being

The study's findings highlight the need for effective and well-tolerated treatment options for managing agitated psychotic patients. I.m. ziprasidone, with its demonstrated efficacy and favorable side effect profile, could offer a safer and more effective alternative to traditional antipsychotics. This could lead to improved patient care and overall well-being for individuals struggling with acute agitation.

Dr.Camel's Conclusion

The search for effective treatments for agitated psychotic patients can be like a camel seeking a cool oasis in a scorching desert. This research sheds light on the potential of i.m. ziprasidone, offering a promising alternative that could bring relief and improve the quality of life for those experiencing agitation. It's a step forward in the quest to find the most effective and humane approaches to managing mental health challenges.

Date :
  1. Date Completed 2001-03-29
  2. Date Revised 2019-08-31
Further Info :

Pubmed ID

11235922

DOI: Digital Object Identifier

10.4088/jcp.v62n0104

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.